Pharmaceutical companies stop pay-offs to doctors. Will this reverse America's drug-dependency trend?

It seems almost unbelievable, but in the United States and some other countries it is common practice for pharmaceutical companies to pay doctors to promote their drugs to patients. Additionally, those same companies have established sales quotas for the detailers of their prescription drugs, pushing dealers to push them on patients. This seeming conflict of interest may very well be responsible for the fact that nearly 70 percent of Americans are on at least one prescription drug, and more than half are taking at two or more prescription drugs. This week, GlaxoSmithKline, one of the world's biggest Big Pharma companies said it will stop paying doctors to promote their drugs. Industry experts think that other pharmaceutical companies are sure to follow Glaxo's lead. Will people start to take fewer drugs now that doctors have less of an incentive to push them on their patients? Watch this trend.